Imaging Surrogates of Tumor Response to Therapy: Anatomic and Functional Biomarkers

被引：64
作者：
Zhao, Binsheng [1 ,2 ]
Schwartz, Lawrence H. [2 ]
Larson, Steve M. [2 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2009年 / 50卷 / 02期
关键词：
response assessment; surrogate biomarker; functional/molecular imaging; volumetric CT; lung cancer; POSITRON-EMISSION-TOMOGRAPHY; CELL LUNG-CANCER; PROLIFERATION IN-VIVO; DNA FLOW-CYTOMETRY; F-18-FDG PET; PROSTATE-CANCER; METABOLIC MEASUREMENTS; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; PROGNOSTIC VALUE;
D O I：
10.2967/jnumed.108.056655
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
This article addresses the current status of quantitative imaging as a surrogate biomarker for the assessment of tumor response to therapy with non-small cell lung cancer as an example. In addition, the article discusses the limitations of conventional response criteria in the new era of molecular-targeted agent for cancer treatment; the increasing need for more accurate and early response-assessment methods, particularly for volumetric CT; new tumor-specific radiotracers and molecular imaging technologies; and the future applications of molecular imaging with PET for studying various features of cancer metabolism, endocrine status, hypoxia, and oncofetal and differentiation antigens.
引用
收藏
页码：239 / 249
页数：11
相关论文
共 81 条
[1]  
*AM CANC SOC, 2008, CANC FACTS FIG 2008, P13
[2]  
Bonasera TA, 1996, J NUCL MED, V37, P1009
[3]   Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].
Choi, Haesun ;
Charnsangavej, Chuslip ;
Faria, Silvana C. ;
Macapinlac, Homer A. ;
Burgess, Michael A. ;
Patel, Shreyaskumar R. ;
Chen, Lei L. ;
Podoloff, Donald A. ;
Benjamin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759
[4]   Critical issues in response evaluation on computed tomography: Lessons from the gastrointestinal stromal tumor model [J].
Choi H. .
Current Oncology Reports, 2005, 7 (4) :307-311
[5]  
Cobben DCP, 2004, J NUCL MED, V45, P1677
[6]   Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer [J].
de Geus-Oei, Lioe-Fee ;
van der Heijden, Henricus F. M. ;
Visser, Eric P. ;
Hermsen, Rick ;
van Hoorn, Bas A. ;
Timmer-Bonte, Johanna N. H. ;
Willemsen, Antoon T. ;
Pruim, Jan ;
Corstens, Frans H. M. ;
Krabbe, Paul F. M. ;
Oyen, Wim J. G. .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (10) :1592-1598
[7]   Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer - A systematic review [J].
de Geus-Oei, Lioe-Fee ;
van der Heijden, Henricus F. M. ;
Corstens, Frans H. M. ;
Oyen, Wirn J. G. .
CANCER, 2007, 110 (08) :1654-1664
[8]   Prognostic value of different metabolic measurements with fluorine-18 fluorodeoxyglucose positron emission tomography in resectable non-small cell lung cancer: A two-center study [J].
de Jong, Wouter K. ;
van der Heijden, Henricus F. M. ;
Pruim, Jan ;
Dalesio, Otilia ;
Oyen, Wim J. G. ;
Groen, Harry J. M. .
JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (11) :1007-1012
[9]   Brick by brick: metabolism and tumor cell growth [J].
DeBerardinis, Ralph J. ;
Sayed, Nabil ;
Ditsworth, Dara ;
Thompson, Craig B. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2008, 18 (01) :54-61
[10]   The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation [J].
DeBerardinis, Ralph J. ;
Lum, Julian J. ;
Hatzivassiliou, Georgia ;
Thompson, Craig B. .
CELL METABOLISM, 2008, 7 (01) :11-20
123456789